Building the Opioid-Sparing Protocol: What the Preclinical Data Actually Says

Written By Niki DeValk

The Shift Away from Opioid-Only Analgesia

Across both clinical medicine and translational research, the conversation surrounding pain management has changed dramatically over the past decade. While opioids remain an important component of perioperative analgesia, increasing attention is being placed on multimodal analgesia strategies that reduce opioid requirements while maintaining—or improving—patient comfort.

In preclinical research, this shift presents unique challenges. Unlike clinical patients, laboratory animal species differ significantly in pain expression, drug metabolism, pharmacokinetics, and validated assessment tools. As a result, many opioid-sparing protocols currently used in research are built from a combination of species-specific evidence, veterinary clinical experience, and extrapolation from human medicine.

The question becomes: What do we actually know, and where are we still making educated assumptions?

___________________________________________________________________________________________________________________________________________________________

What Is Multimodal Analgesia?

Multimodal analgesia is the use of multiple analgesic mechanisms simultaneously to target different pathways within the pain cascade.

Rather than relying on a single drug class, protocols typically combine:

  • Opioids

  • NSAIDs

  • Local anesthetics

  • NMDA receptor antagonists

  • Alpha-2 agonists

  • Gabapentinoids

  • Regional anesthesia techniques

The goal is simple:

  • Reduce overall pain burden

  • Improve recovery quality

  • Minimize opioid-related adverse effects

  • Maintain physiologic stability

  • Enhance translational relevance

In large animal models, these benefits often extend beyond animal welfare by reducing anesthetic requirements and improving procedural consistency.

___________________________________________________________________________________________________________________________________________________________

Species-by-Species Review

Swine

What Is Well Supported?

Swine possess some of the strongest preclinical evidence supporting multimodal analgesia.

Validated approaches commonly include:

NSAIDs

  • Meloxicam

  • Carprofen

  • Flunixin meglumine

Local and Regional Techniques

  • Line blocks

  • Splash blocks

  • Epidurals

  • Intercostal blocks

  • Transversus abdominis plane (TAP) blocks

Opioids

  • Buprenorphine

  • Fentanyl CRI

  • Morphine

Research consistently demonstrates improved comfort when NSAIDs and local anesthetics are incorporated alongside opioid therapy.

Emerging Evidence

Growing literature supports:

  • Lidocaine CRIs

  • Ketamine CRIs

  • Dexmedetomidine adjuncts

These agents frequently reduce inhalant anesthetic requirements and improve perioperative stability.

Current Gaps

Major limitations include:

  • Limited validation of chronic pain models

  • Variable pharmacokinetic data between breeds

  • Inconsistent pain scoring systems

  • Limited long-term outcome studies

For many advanced protocols, evidence remains procedural rather than species-wide.

Sheep (Ovine Models)

What Is Well Supported?

Sheep are increasingly utilized in orthopedic, cardiovascular, and regenerative medicine studies.

Commonly validated approaches include:

  • Meloxicam

  • Flunixin meglumine

  • Buprenorphine

  • Epidural morphine

Regional anesthesia techniques continue to gain support, particularly for orthopedic procedures.

Emerging Evidence

Studies evaluating:

  • Continuous local anesthetic infusion

  • Ketamine adjunct protocols

  • Multimodal orthopedic pain management have demonstrated promising results.

Current Gaps

Pain assessment remains one of the largest challenges.

Unlike companion animal species, sheep often mask discomfort and exhibit subtle behavioral changes, making protocol optimization difficult.

Goats (Caprine Models)

What Is Well Supported?

Caprine-specific literature remains comparatively sparse.

Current protocols frequently utilize:

  • Meloxicam

  • Flunixin

  • Buprenorphine supported by limited species-specific studies.

What Is Often Extrapolated?

Many perioperative recommendations originate from:

  • Ovine literature

  • Production animal medicine

  • Clinical ruminant practice

This approach is generally reasonable but highlights the lack of dedicated caprine analgesia research.

Current Gaps

Significant opportunities exist for:

  • Pharmacokinetic studies

  • Pain scoring validation

  • Regional anesthesia research

  • Long-term recovery assessments

Canine Models

What Is Well Supported?

Dogs possess one of the most extensive evidence bases in veterinary medicine.

Validated multimodal approaches include:

  • Opioids

  • NSAIDs

  • Local anesthetics

  • Ketamine infusions

  • Gabapentin

  • Regional anesthesia

The veterinary literature provides robust support for opioid-sparing protocols in both soft tissue and orthopedic procedures.

Emerging Evidence

Continued work is evaluating:

  • Long-duration local anesthetics

  • Liposomal formulations

  • Novel neuropathic pain therapies

Current Gaps

Most remaining questions involve optimization rather than efficacy.

Nonhuman Primates

What Is Well Supported?

Analgesic recommendations generally include:

  • Buprenorphine

  • NSAIDs

  • Local anesthetic techniques

Physiologically, these models often translate well to human medicine.

Current Challenges

Research is frequently limited by:

  • Ethical constraints

  • Small study populations

  • Institutional variability

As a result, many recommendations rely on expert consensus rather than large controlled studies.

The Regional Anesthesia Revolution

One of the most significant developments in opioid-sparing protocols has been the expansion of regional anesthesia.

Techniques increasingly utilized in research settings include:

  • TAP blocks

  • Epidurals

  • Intercostal blocks

  • Femoral nerve blocks

  • Sciatic nerve blocks

  • Wound infiltration catheters

These approaches offer several advantages:

  • Reduced opioid requirements

  • Improved recovery quality

  • Lower inhalant requirements

  • Enhanced physiologic stability

As ultrasound-guided techniques become more accessible, regional anesthesia is likely to become a standard component of many preclinical surgical models.

___________________________________________________________________________________________________________________________________________________________

Where the Evidence Is Still Weak

Despite growing enthusiasm for multimodal analgesia, several limitations remain.

Lack of Standardized Pain Assessment

Pain scoring systems differ widely across species and institutions.

Limited Comparative Studies

Few studies directly compare:

  • Opioid-only protocols

  • Traditional multimodal protocols

  • Advanced opioid-sparing strategies under controlled conditions.

___________________________________________________________________________________________________________________________________________________________

Translational Assumptions

Many protocols are adopted from:

  • Human medicine

  • Companion animal practice

  • Other laboratory species without direct validation in the target model.

Practical Takeaways for Research Teams

When developing an opioid-sparing protocol:

  • Start With What Is Validated

    • Use species-specific evidence whenever available.

  • Incorporate Local Anesthesia Early

    • Regional techniques often provide the greatest reduction in opioid requirements.

  • Match Analgesia to Procedure Severity

    • A minimally invasive survival procedure and a complex thoracotomy should not receive the same pain management strategy.

  • Monitor Outcomes Objectively, track:

    • Recovery quality

    • Food intake

    • Behavior

    • Physiologic parameters

    • Rescue analgesia requirements

These metrics often reveal protocol effectiveness better than drug selection alone.

___________________________________________________________________________________________________________________________________________________________

Final Thoughts

The movement toward opioid-sparing analgesia is not about eliminating opioids. It is about building evidence-based, multimodal frameworks that improve animal welfare, procedural consistency, and translational relevance.

For swine, canine, and some ovine models, the evidence supporting multimodal analgesia is increasingly strong. For caprine and certain specialty species, significant knowledge gaps remain.

As preclinical research continues to evolve, the most effective protocols will be those grounded in species-specific data, refined through objective outcome measures, and adapted to the unique demands of each model.

Through NiKara Preclinical, my protocol development begins with a simple principle: Use the best available evidence, acknowledge where evidence is lacking, and continuously refine based on data.

Niki DeValk, AAS, CVT, SRS

NiKara Preclinical

niki@nikarapreclinical.com | 612.770.7839 | nikarapreclinical.com

Niki DeValk
Next

The Critical Role of Pre-Procedural Planning in Large Animal Surgical Models